All circulating EpCAM+CK+CD45− objects predict overall survival in castration-resistant prostate cancer
Identifieur interne : 000D85 ( Main/Exploration ); précédent : 000D84; suivant : 000D86All circulating EpCAM+CK+CD45− objects predict overall survival in castration-resistant prostate cancer
Auteurs : F. A. W. Coumans [Pays-Bas] ; C. J. M. Doggen [Pays-Bas] ; G. Attard [Royaume-Uni] ; J. S. De Bono [Royaume-Uni] ; L. W. M. M. Terstappen [Pays-Bas]Source :
- Annals of Oncology [ 0923-7534 ] ; 2010-09.
Abstract
Background: Presence of five or more circulating tumor cells (CTC) in patients with metastatic carcinomas is associated with poor survival. Although many objects positive for epithelial cell adhesion molecules and cytokeratin (EpCAM+CK+) are not counted as CTC, they may be an important predictor for survival. We evaluated the association between these objects and survival in patients with prostate cancer. Patients and methods: Included in this follow-up study were 179 patients with castration-resistant prostate cancer. CellSearch was used to isolate EpCAM+ objects and to stain DNA, cytokeratin and CD45. All EpCAM+CK+ objects were subdivided into seven classes on the basis of predefined morphological appearance in 63 independent samples. Association of each class with survival was studied using Kaplan–Meier and Cox regression analyses. Results: Each EpCAM+CK+CD45− class showed a strong association with overall survival (P < 0.001). This included small tumor microparticles (S-TMP), which did not require a nucleus and thus are unable to metastasize. A higher number of objects in any class was associated with decreased survival. A good prediction model included large tumor cell fragments (L-TCF), age, hemoglobin and lactate dehydrogenase. Models with S-TMP or CTC instead of L-TCF performed similarly. Conclusion: EpCAM+CK+CD45− that do not meet strict definitions for CTC are strong prognostic markers for survival.
Url:
DOI: 10.1093/annonc/mdq030
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001763
- to stream Istex, to step Curation: 001763
- to stream Istex, to step Checkpoint: 000109
- to stream Main, to step Merge: 000F60
- to stream Main, to step Curation: 000D85
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>All circulating EpCAM+CK+CD45− objects predict overall survival in castration-resistant prostate cancer</title><author><name sortKey="Coumans, F A W" sort="Coumans, F A W" uniqKey="Coumans F" first="F. A. W." last="Coumans">F. A. W. Coumans</name></author><author><name sortKey="Doggen, C J M" sort="Doggen, C J M" uniqKey="Doggen C" first="C. J. M." last="Doggen">C. J. M. Doggen</name></author><author><name sortKey="Attard, G" sort="Attard, G" uniqKey="Attard G" first="G." last="Attard">G. Attard</name></author><author><name sortKey="De Bono, J S" sort="De Bono, J S" uniqKey="De Bono J" first="J. S." last="De Bono">J. S. De Bono</name></author><author><name sortKey="Terstappen, L W M M" sort="Terstappen, L W M M" uniqKey="Terstappen L" first="L. W. M. M." last="Terstappen">L. W. M. M. Terstappen</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:B95182D58DA05578B50B7C1988376EC114570007</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1093/annonc/mdq030</idno><idno type="url">https://api.istex.fr/document/B95182D58DA05578B50B7C1988376EC114570007/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001763</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001763</idno><idno type="wicri:Area/Istex/Curation">001763</idno><idno type="wicri:Area/Istex/Checkpoint">000109</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000109</idno><idno type="wicri:doubleKey">0923-7534:2010:Coumans F:all:circulating:epcam</idno><idno type="wicri:Area/Main/Merge">000F60</idno><idno type="wicri:Area/Main/Curation">000D85</idno><idno type="wicri:Area/Main/Exploration">000D85</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">All circulating EpCAMCKCD45 objects predict overall survival in castration-resistant prostate cancer</title><author><name sortKey="Coumans, F A W" sort="Coumans, F A W" uniqKey="Coumans F" first="F. A. W." last="Coumans">F. A. W. Coumans</name><affiliation wicri:level="4"><country>Pays-Bas</country><placeName><settlement type="city">Enschede</settlement><region nuts="2">Overijssel</region></placeName><orgName type="university">Université de Twente</orgName></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Pays-Bas</country></affiliation><affiliation><wicri:noCountry code="syntax">???</wicri:noCountry></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Pays-Bas</country></affiliation></author><author><name sortKey="Doggen, C J M" sort="Doggen, C J M" uniqKey="Doggen C" first="C. J. M." last="Doggen">C. J. M. Doggen</name><affiliation wicri:level="4"><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Health Technology & Services Research, University of Twente, Enschede</wicri:regionArea><orgName type="university">Université de Twente</orgName><placeName><settlement type="city">Enschede</settlement><region nuts="2">Overijssel</region></placeName></affiliation></author><author><name sortKey="Attard, G" sort="Attard, G" uniqKey="Attard G" first="G." last="Attard">G. Attard</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Drug Development Unit, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, Surrey</wicri:regionArea><wicri:noRegion>Surrey</wicri:noRegion></affiliation></author><author><name sortKey="De Bono, J S" sort="De Bono, J S" uniqKey="De Bono J" first="J. S." last="De Bono">J. S. De Bono</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Drug Development Unit, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, Sutton, Surrey</wicri:regionArea><wicri:noRegion>Surrey</wicri:noRegion></affiliation></author><author><name sortKey="Terstappen, L W M M" sort="Terstappen, L W M M" uniqKey="Terstappen L" first="L. W. M. M." last="Terstappen">L. W. M. M. Terstappen</name><affiliation wicri:level="4"><country>Pays-Bas</country><placeName><settlement type="city">Enschede</settlement><region nuts="2">Overijssel</region></placeName><orgName type="university">Université de Twente</orgName></affiliation></author></analytic><monogr></monogr><series><title level="j">Annals of Oncology</title><idno type="ISSN">0923-7534</idno><idno type="eISSN">1569-8041</idno><imprint><publisher>Oxford University Press</publisher><date type="published" when="2010-09">2010-09</date><biblScope unit="volume">21</biblScope><biblScope unit="issue">9</biblScope><biblScope unit="page" from="1851">1851</biblScope><biblScope unit="page" to="1857">1857</biblScope></imprint><idno type="ISSN">0923-7534</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0923-7534</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract">Background: Presence of five or more circulating tumor cells (CTC) in patients with metastatic carcinomas is associated with poor survival. Although many objects positive for epithelial cell adhesion molecules and cytokeratin (EpCAM+CK+) are not counted as CTC, they may be an important predictor for survival. We evaluated the association between these objects and survival in patients with prostate cancer. Patients and methods: Included in this follow-up study were 179 patients with castration-resistant prostate cancer. CellSearch was used to isolate EpCAM+ objects and to stain DNA, cytokeratin and CD45. All EpCAM+CK+ objects were subdivided into seven classes on the basis of predefined morphological appearance in 63 independent samples. Association of each class with survival was studied using Kaplan–Meier and Cox regression analyses. Results: Each EpCAM+CK+CD45− class showed a strong association with overall survival (P < 0.001). This included small tumor microparticles (S-TMP), which did not require a nucleus and thus are unable to metastasize. A higher number of objects in any class was associated with decreased survival. A good prediction model included large tumor cell fragments (L-TCF), age, hemoglobin and lactate dehydrogenase. Models with S-TMP or CTC instead of L-TCF performed similarly. Conclusion: EpCAM+CK+CD45− that do not meet strict definitions for CTC are strong prognostic markers for survival.</div></front></TEI><affiliations><list><country><li>Pays-Bas</li><li>Royaume-Uni</li></country><region><li>Overijssel</li></region><settlement><li>Enschede</li></settlement><orgName><li>Université de Twente</li></orgName></list><tree><country name="Pays-Bas"><region name="Overijssel"><name sortKey="Coumans, F A W" sort="Coumans, F A W" uniqKey="Coumans F" first="F. A. W." last="Coumans">F. A. W. Coumans</name></region><name sortKey="Coumans, F A W" sort="Coumans, F A W" uniqKey="Coumans F" first="F. A. W." last="Coumans">F. A. W. Coumans</name><name sortKey="Coumans, F A W" sort="Coumans, F A W" uniqKey="Coumans F" first="F. A. W." last="Coumans">F. A. W. Coumans</name><name sortKey="Doggen, C J M" sort="Doggen, C J M" uniqKey="Doggen C" first="C. J. M." last="Doggen">C. J. M. Doggen</name><name sortKey="Terstappen, L W M M" sort="Terstappen, L W M M" uniqKey="Terstappen L" first="L. W. M. M." last="Terstappen">L. W. M. M. Terstappen</name></country><country name="Royaume-Uni"><noRegion><name sortKey="Attard, G" sort="Attard, G" uniqKey="Attard G" first="G." last="Attard">G. Attard</name></noRegion><name sortKey="De Bono, J S" sort="De Bono, J S" uniqKey="De Bono J" first="J. S." last="De Bono">J. S. De Bono</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Lorraine/explor/LrgpV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D85 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D85 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Lorraine
|area= LrgpV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:B95182D58DA05578B50B7C1988376EC114570007
|texte= All circulating EpCAM+CK+CD45− objects predict overall survival in castration-resistant prostate cancer
}}
| This area was generated with Dilib version V0.6.32. |  |